• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青蒿素耐药性和恶性疟原虫清除的阶段依赖性。

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.

机构信息

Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, Churchill Hospital, Oxford, United Kingdom.

出版信息

J Infect Dis. 2019 Apr 16;219(9):1483-1489. doi: 10.1093/infdis/jiy673.

DOI:10.1093/infdis/jiy673
PMID:30657916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6467186/
Abstract

BACKGROUND

Artemisinin resistance in falciparum malaria is associated with kelch13 propeller mutations, reduced ring stage parasite killing, and, consequently, slow parasite clearance. We assessed how parasite age affects parasite clearance in artemisinin resistance.

METHODS

Developmental stages of Plasmodium falciparum parasites on blood films performed at hospital admission and their kelch13 genotypes were assessed for 816 patients enrolled in a multinational clinical trial of artemisinin combination therapy.

RESULTS

Early changes in parasitemia level (ie, 0-6 hours after admission) were determined mainly by modal stage of asexual parasite development, whereas the subsequent log-linear decline was determined mainly by kelch13 propeller mutations. Older circulating parasites on admission were associated with more-rapid parasite clearance, particularly in kelch13 mutant infections. The geometric mean parasite clearance half-life decreased by 11.6% (95% CI 3.4%-19.1%) in kelch13 wild-type infections and by 30% (95% CI 17.8%-40.4%) in kelch13 mutant infections as the mean age of circulating parasites rose from 3 to 21 hours.

CONCLUSION

Following the start of antimalarial treatment, ongoing parasite sequestration and schizogony both affect initial changes in parasitemia. The greater dependency of parasite clearance half-life on parasite age in artemisinin resistant infections is consistent with ring stage resistance and consequent parasite clearance by sequestration. The stage of parasite development should be incorporated in individual assessments of artemisinin resistance.

摘要

背景

恶性疟原虫对青蒿素的抗药性与 kelch13 推进器突变、减少环状体寄生虫杀伤以及随后的寄生虫清除率降低有关。我们评估了寄生虫年龄如何影响青蒿素耐药性中的寄生虫清除。

方法

在一项多中心青蒿素联合疗法临床试验中,对 816 名患者入院时的血片进行了疟原虫发育阶段评估及其 kelch13 基因型分析。

结果

寄生虫血症水平的早期变化(即入院后 0-6 小时)主要取决于无性体寄生虫发育的模态阶段,而随后的对数线性下降主要取决于 kelch13 推进器突变。入院时循环寄生虫的年龄越大,寄生虫清除越快,尤其是在 kelch13 突变感染中。kelch13 野生型感染中寄生虫清除半衰期的几何平均减少 11.6%(95%CI 3.4%-19.1%),kelch13 突变型感染中寄生虫清除半衰期的几何平均减少 30%(95%CI 17.8%-40.4%),随着循环寄生虫的平均年龄从 3 小时增加到 21 小时。

结论

在开始抗疟治疗后,持续的寄生虫隔离和裂殖子生成均会影响寄生虫血症的初始变化。在青蒿素耐药感染中,寄生虫清除半衰期对寄生虫年龄的依赖性更大,这与环状体耐药和随后的寄生虫隔离清除一致。在个体评估青蒿素耐药性时,应将寄生虫发育阶段纳入其中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a676/6467186/8d8b0d8df944/jiy673f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a676/6467186/8d8b0d8df944/jiy673f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a676/6467186/8d8b0d8df944/jiy673f0001.jpg

相似文献

1
Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.青蒿素耐药性和恶性疟原虫清除的阶段依赖性。
J Infect Dis. 2019 Apr 16;219(9):1483-1489. doi: 10.1093/infdis/jiy673.
2
Spread of artemisinin resistance in Plasmodium falciparum malaria.疟原虫青蒿素耐药性的传播。
N Engl J Med. 2014 Jul 31;371(5):411-23. doi: 10.1056/NEJMoa1314981.
3
Naturally Acquired Kelch13 Mutations in Plasmodium falciparum Strains Modulate Ring-Stage Artemisinin-Based Drug Tolerance and Parasite Survival in Response to Hyperoxia.疟原虫中Kelch13 自然突变可调节环早期青蒿素类药物耐药性和寄生虫对高氧的存活能力
Microbiol Spectr. 2022 Oct 26;10(5):e0128221. doi: 10.1128/spectrum.01282-21. Epub 2022 Sep 12.
4
The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.青蒿素类药物诱导的寄生虫清除对非洲恶性疟原虫疟疾的影响。
Clin Infect Dis. 2023 May 3;76(9):1585-1593. doi: 10.1093/cid/ciac944.
5
Pairwise growth competitions identify relative fitness relationships among artemisinin resistant Plasmodium falciparum field isolates.成对生长竞争鉴定青蒿素耐药恶性疟原虫野外分离株之间的相对适应性关系。
Malar J. 2019 Aug 28;18(1):295. doi: 10.1186/s12936-019-2934-4.
6
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.柬埔寨三突变(包括kelch13 C580Y)导致双氢青蒿素-哌喹耐药:一项观察性队列研究。
Lancet Infect Dis. 2015 Jun;15(6):683-91. doi: 10.1016/S1473-3099(15)70049-6. Epub 2015 Apr 12.
7
Novel pfkelch13 Gene Polymorphism Associates With Artemisinin Resistance in Eastern India.新型 pfkelch13 基因突变与印度东部的青蒿素耐药性相关。
Clin Infect Dis. 2019 Sep 13;69(7):1144-1152. doi: 10.1093/cid/ciy1038.
8
Artemisinin Action and Resistance in Plasmodium falciparum.青蒿素在恶性疟原虫中的作用与耐药性
Trends Parasitol. 2016 Sep;32(9):682-696. doi: 10.1016/j.pt.2016.05.010. Epub 2016 Jun 9.
9
Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis.基于青蒿素的治疗后寄生虫清除率与疟原虫 falciparum Kelch13 基因(Pf3D7_1343700)突变的关联:一项 WWARN 个体患者数据荟萃分析。
BMC Med. 2019 Jan 17;17(1):1. doi: 10.1186/s12916-018-1207-3.
10
Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.界定青蒿素耐药恶性疟原虫的体内表型:一种建模方法。
PLoS Med. 2015 Apr 28;12(4):e1001823. doi: 10.1371/journal.pmed.1001823. eCollection 2015 Apr.

引用本文的文献

1
Expansion of the R622I Mutation in Northwest Ethiopia.埃塞俄比亚西北部R622I突变的扩展
Open Forum Infect Dis. 2025 May 9;12(6):ofaf279. doi: 10.1093/ofid/ofaf279. eCollection 2025 Jun.
2
Detection of novel haplotypes under treatment pressure in paediatric severe malaria.小儿重症疟疾治疗压力下新型单倍型的检测
Microb Genom. 2025 May;11(5). doi: 10.1099/mgen.0.001386.
3
Identification of an artemisinin-resistant kelch13 R515K mutant parasite in Senegal.在塞内加尔发现一株对青蒿素耐药的kelch13基因R515K突变疟原虫。

本文引用的文献

1
Host immunity to and the assessment of emerging artemisinin resistance in a multinational cohort.多国队列研究中的宿主免疫与青蒿素耐药性的评估。
Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3515-3520. doi: 10.1073/pnas.1615875114. Epub 2017 Mar 13.
2
Malaria parasite clearance.疟原虫清除
Malar J. 2017 Feb 23;16(1):88. doi: 10.1186/s12936-017-1731-1.
3
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.恶性疟原虫K13螺旋桨多态性的全球地图。
Front Parasitol. 2023 Apr 28;2:1076759. doi: 10.3389/fpara.2023.1076759. eCollection 2023.
4
Artemisinin-resistant malaria.抗青蒿素疟疾
Clin Microbiol Rev. 2024 Dec 10;37(4):e0010924. doi: 10.1128/cmr.00109-24. Epub 2024 Oct 15.
5
In artemisinin-resistant falciparum malaria parasites, mitochondrial metabolic pathways are essential for survival but not those of apicoplast.在对青蒿素耐药的恶性疟原虫中,线粒体代谢途径对其生存至关重要,而质体的代谢途径则不然。
Int J Parasitol Drugs Drug Resist. 2024 Dec;26:100565. doi: 10.1016/j.ijpddr.2024.100565. Epub 2024 Sep 19.
6
Artemisinin resistance and malaria elimination: Where are we now?青蒿素耐药性与疟疾消除:我们目前处于什么状况?
Front Pharmacol. 2022 Sep 23;13:876282. doi: 10.3389/fphar.2022.876282. eCollection 2022.
7
Severe malaria.严重疟疾。
Malar J. 2022 Oct 6;21(1):284. doi: 10.1186/s12936-022-04301-8.
8
Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia.比较刚果民主共和国和亚洲地区青蒿素疗效研究中的抗体反应和寄生虫清除率。
J Infect Dis. 2022 Aug 24;226(2):324-331. doi: 10.1093/infdis/jiac232.
9
The assessment of antimalarial drug efficacy in vivo.体内抗疟药物功效评估。
Trends Parasitol. 2022 Aug;38(8):660-672. doi: 10.1016/j.pt.2022.05.008. Epub 2022 Jun 6.
10
Machine learning for artemisinin resistance in malaria treatment across platforms.跨平台疟疾治疗中青蒿素耐药性的机器学习
iScience. 2022 Feb 10;25(3):103910. doi: 10.1016/j.isci.2022.103910. eCollection 2022 Mar 18.
N Engl J Med. 2016 Jun 23;374(25):2453-64. doi: 10.1056/NEJMoa1513137.
4
Defining the Effectiveness of Antimalarial Chemotherapy: Investigation of the Lag in Parasite Clearance Following Drug Administration.确定抗疟化疗的有效性:药物给药后寄生虫清除延迟的研究。
J Infect Dis. 2016 Sep 1;214(5):753-61. doi: 10.1093/infdis/jiw234. Epub 2016 May 31.
5
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.青蒿素衍生物治疗恶性疟患者寄生虫清除的基线数据:一项个体患者数据荟萃分析。
Malar J. 2015 Sep 22;14:359. doi: 10.1186/s12936-015-0874-1.
6
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?疟疾寄生虫清除率作为药物有效性和耐药性指标的稳健性如何?
Antimicrob Agents Chemother. 2015 Oct;59(10):6428-36. doi: 10.1128/AAC.00481-15. Epub 2015 Aug 3.
7
Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance.靶向恶性疟原虫的细胞应激反应以克服青蒿素耐药性。
PLoS Biol. 2015 Apr 22;13(4):e1002132. doi: 10.1371/journal.pbio.1002132. eCollection 2015 Apr.
8
Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytes.对青蒿素耐药的恶性疟原虫在受感染红细胞中表现出不同的发育模式。
Antimicrob Agents Chemother. 2015;59(6):3156-67. doi: 10.1128/AAC.00197-15. Epub 2015 Mar 16.
9
Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.在用青蒿琥酯治疗疟疾的马里免疫儿童中,恶性疟原虫清除迅速且与凹痕无关。
J Infect Dis. 2015 Jan 15;211(2):290-7. doi: 10.1093/infdis/jiu427. Epub 2014 Sep 2.
10
Spread of artemisinin resistance in Plasmodium falciparum malaria.疟原虫青蒿素耐药性的传播。
N Engl J Med. 2014 Jul 31;371(5):411-23. doi: 10.1056/NEJMoa1314981.